Today ’s Wordle #540 Hints, Clues And Answer For Sunday, December 11th
Do you hear that folks? That’s the sound of Christmas closing in. Jingle Bells and reindeer hooves mucking up your shingles. The mad cackle of elves in the nippy gloaming air. Winter is coming. A part of me wishes that Christmas came later on in the season. I’m a big fan of Christmas (especially…#santa #hintyoung #howtosolvetodayswordle #jinglebells #sigh #wordlebot #swordle (Source: Reuters: Health)
Source: Reuters: Health - December 11, 2022 Category: Consumer Health News Source Type: news
GSK gets regulatory nod to launch shingles vaccine in India
Piyali Mukherjee, vice president and head of global medical affairs, vaccines, at GSK said the virus is there in 90% of adults and whenever the immunities hit, the virus is reactivated and that's when one gets the symptoms of shingles. (Source: The Economic Times)
Source: The Economic Times - December 7, 2022 Category: Consumer Health News Source Type: news
Shingles Ups Odds of Stroke, Heart Attack By Almost 30%
A new, large study suggests people who've had a bout of shingles may face a heightened risk of heart attack or stroke in later years. (Source: WebMD Health)
Source: WebMD Health - December 5, 2022 Category: Consumer Health News Source Type: news
Shingles Ups Odds of Stroke, Heart Attack By Almost 30%
MONDAY, Dec. 5, 2022 -- People who ' ve had a bout of shingles may face a heightened risk of heart attack or stroke in later years, a new, large study suggests.
Anyone who ever had chickenpox can develop shingles — a painful rash that is caused by a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2022 Category: General Medicine Source Type: news
Mayo Clinic Q and A: Shingles -- not just a band of blisters
DEAR MAYO CLINIC: A friend recently went through a bout of shingles. I really don't know much about this condition, but I know it was painful. How do you get it? Is there a treatment or vaccine for it? ANSWER: Shingles, also known as herpes zoster, is a common condition caused by the varicella-zoster virus, which also causes chickenpox. Not everyone who has had chickenpox will develop shingles. However, after years of lying dormant in nerve tissue… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 28, 2022 Category: Databases & Libraries Source Type: news
Shingles may hike the risk of having a heart attack by up to 60% - signs you should know
Shingles cause long-term damage to the fibres and skin, but new evidence suggests it may also spur inflammation in blood vessels. (Source: Daily Express - Health)
Source: Daily Express - Health - November 25, 2022 Category: Consumer Health News Source Type: news
Shingles Associated with Increased Risk for Stroke, Heart Attack
Study of more than 200,000 people demonstrated that herpes zoster (shingles) is associated with an almost 30% higher long-term risk of a major cardiovascular event (Source: BWH News)
Source: BWH News - November 22, 2022 Category: Hospital Management Source Type: news
Large U.S. Study Finds No Link Between COVID Vaccine and Shingles
(MedPage Today) -- No association was detected between COVID-19 vaccination and herpes zoster infection in a database study involving more than 2 million individuals in the U.S.
Using a self-controlled risk interval (SCRI) analysis, the risk of... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - November 16, 2022 Category: Dermatology Source Type: news
GSK lifts profit and sales guidance after shingles vaccine boost
UK drugmaker beats forecasts and ‘expects good momentum in 2023’ (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - November 2, 2022 Category: Pharmaceuticals Source Type: news
STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Through Four Years in Adults with Moderately to Severely Active Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final data from the long-term extension (LTE) of the Phase 3 UNIFI study demonstrating efficacy and safety of STELARA® (ustekinumab) through four years of treatment in adult patients with moderately to severely active ulcerative colitis (UC).1 Among all patients who had achieved clinical responsea with STELARA during induction, 64.9 percent were in symptomatic remissionb after 44 weeks of maintenance. At week 200 (four years), this proportion of patients was 55.2 percent; the majority (96.4 percen...
Source: Johnson and Johnson - October 10, 2022 Category: Pharmaceuticals Source Type: news
Shingles: 'Long-term' use of corticosteroids can trigger reactivation of chickenpox virus
Using a common medication regularly can increase your risk of a shingles flare-up. (Source: Daily Express - Health)
Source: Daily Express - Health - September 25, 2022 Category: Consumer Health News Source Type: news
Shingles: The warning signs that appear 'several days' before the telltalle rash
ALTHOUGH shingles is characterised by a painful rash, there are three sensations that might be the first to alert you of the viral infection. (Source: Daily Express - Health)
Source: Daily Express - Health - September 18, 2022 Category: Consumer Health News Source Type: news
Shingles symptom can cause ‘permanent’ eye damage if not treated quickly - ‘See a doctor'
SHINGLES is an infection that results in an unpleasant and itchy rash. Luckily for most people the infection and its side effects fade after a few weeks. But others might be left with permanent health issues as a result. (Source: Daily Express - Health)
Source: Daily Express - Health - September 10, 2022 Category: Consumer Health News Source Type: news
Shingles symptom linked to vision may cause ‘severe’ problems - Call a doctor 'right away'
WHEN most of us think of shingles we picture an itchy, red rash first. However, there are a whole host of other symptoms that can occur. And some of these could then lead to other "severe" problems. (Source: Daily Express - Health)
Source: Daily Express - Health - August 24, 2022 Category: Consumer Health News Source Type: news
Boston biotech raises $109M to fuel platform for vaccines, crop protection
A biotechnology company headquartered in Boston is advancing its work on crop protection and developing vaccines for Covid-19 and shingles. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 23, 2022 Category: Biotechnology Authors: Zac Ezzone Source Type: news
